LONDON, UK: Mayfair Equity Partners LLP (MEP), through a wholly-owned indirect subsidiary, Purple Bidco Limited, has offered to acquire entire share capital of Seraphine Group (excluding approximately 42.71 per cent of the voting rights in Seraphine, currently held by Mayfair). The offer of 30 pence/share values the entire issued and to be issued share capital…
Month: January 2023
Ilika and Cirtec Medical to collaborate in manufacturing of miniature Stereax solid-state batteries
LONDON: Ilika Plc, a pioneer in solid-state battery technology, announces it has broadened its relationship with Cirtec Medical (‘Cirtec’), an industry-leading strategic outsourcing partner of complex medical devices including minimally invasive and active implantable devices, by signing a memorandum of understanding (‘MOU’) which outlines the transfer of Stereax mm-scale battery manufacturing to Cirtec’s facility in…
AstraZeneca completes acquisition of Neogene Therapeutics
LONDON: AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts). Neogene will operate as a wholly owned subsidiary of AstraZeneca, with operations in Amsterdam, the Netherlands and California, US. AstraZeneca has acquired all outstanding equity of Neogene…
Totally Plc awarded new contract worth £10 million per annum
LONDON: Totally plc, a leading provider of frontline healthcare services, corporate fitness and wellbeing services across the UK and Ireland, has been awarded a new contract by NHS England to provide national NHS 111 contingency services. The contract, awarded to Vocare Limited (“Vocare”), part of Totally’s Urgent Care division, will run from 1 March 2023…
Ways in which healthcare can use artificial intelligence (AI)
Healthcare is all set to avail benefits of Artificial Intelligence (AI) to make it smarter and enhance the customer experience. Will AI change the way healthcare exists right now? From faster diagnosis, better patients’ understanding to drug management; artificial intelligence in healthcare is becoming a popular discussion. Though AI shows high potential to transform the…
MD Medical Group opens new medical centre in Moscow region
LONDON, UK: MD Medical Group Investments, a leading Russian private healthcare provider, announced the opening of a new out-patient medical centre “Mother&Child Mytishchi” in Moscow Region. The new medical centre with a total area of 235 sq. m. offers a wide range of pregnancy and birth preparation services for women, such as diagnosis and treatment…
Wolters Kluwer Health has acquired NurseTim
AMSTERDAM: Wolters Kluwer Health has acquired NurseTim, a US-based provider of nursing education solutions. NurseTim will become part of Wolters Kluwer’s Health Learning, Research & Practice (HLRP) business, which includes nursing education and practice solutions that help ensure students are ready for practice and nurses are prepared to deliver better patient care and outcomes. NurseTim’s…
EUROAPI to invest €40 million for a more efficient and sustainable production in France
PARIS, FRANCE: EUROAPI has approved a €40 million investment for the implementation of a new production technology dedicated to vitamin B12 at its site in Saint-Aubin-lès-Elbeuf (Seine-Maritime, France). The project should enable EUROAPI to increase its manufacturing capacity by 2025 while reducing its environmental footprint. This investment benefits from a total financial support of €7.9…
Ipsen to acquire Albireo for an initial $952 million
PARIS, FRANCE: Ipsen and Albireo have entered into a definitive merger agreement under which Ipsen will acquire Albireo, a leading innovator in bile-acid modulators to treat pediatric and adult cholestatic liver diseases. The anticipated acquisition will enrich Ipsen’s Rare Disease portfolio and pipeline. The lead medicine in Albireo’s pipeline is Bylvay® (odevixibat), a potent, once-daily,…
AstraZeneca partners LBT Innovations for APAS pharma development
ADELAIDE, AUSTRALIA: Australian medical technology company LBT Innovations Limited (ASX: LBT) has been engaged by AstraZeneca for the full product development for its APAS Pharma product. LBT Innovations has been engaged by AstraZeneca, a global biopharmaceutical company, to undertake a full product development project for the Company’s new APAS® Pharma analysis module (artificial intelligence software)…